Jyoti Rasgania, Renu Gavadia, Neetu Sahu, Pinki Sharma, Nar S Chauhan, Vicky Saharan, Rajeev K Kapoor, Komal Jakhar
{"title":"设计、合成和探索新型三嗪吲哚作为有效的定量感应抑制剂和自由基淬灭剂。","authors":"Jyoti Rasgania, Renu Gavadia, Neetu Sahu, Pinki Sharma, Nar S Chauhan, Vicky Saharan, Rajeev K Kapoor, Komal Jakhar","doi":"10.4155/fmc-2023-0313","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Antimicrobial resistance has become a critical health concern, and quorum-sensing exacerbates the resistance by facilitating cell-to-cell communication within the microbial community, leading to severe pathogenic outbreaks. <b>Methods & results:</b> Novel 1-(2-((5<i>H</i>-[1,2,4]-triazino[5,6-<i>b</i>]indol-3-yl)thio)acetyl)indoline-2,3-diones were synthesized. The title compounds exhibit outstanding anti-quorum-sensing efficacy, and compound <b>7g</b> demonstrated the maximum proficiency (IC<sub>50</sub> = 0.0504 μg/ml). The hybrids displayed potent antioxidant action, and compound <b>7c</b> showed the highest antioxidant ability (IC<sub>50</sub> = 40.71 μg/ml). Molecular docking of the isatin hybrids against DNA gyrase and quorum-sensing receptor CviR validated the observed <i>in vitro</i> findings. The befitting pharmacokinetic profile of the synthesized drug candidates was ascertained through absorption, distribution, metabolism, excretion and toxicity screening. <b>Conclusion:</b> The remarkable biocompetence of the synthesized triazinoindoles may help to combat drug-resistant infections.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":" ","pages":"399-416"},"PeriodicalIF":3.2000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Design, synthesis and exploration of novel triazinoindoles as potent quorum-sensing inhibitors and radical quenchers.\",\"authors\":\"Jyoti Rasgania, Renu Gavadia, Neetu Sahu, Pinki Sharma, Nar S Chauhan, Vicky Saharan, Rajeev K Kapoor, Komal Jakhar\",\"doi\":\"10.4155/fmc-2023-0313\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Antimicrobial resistance has become a critical health concern, and quorum-sensing exacerbates the resistance by facilitating cell-to-cell communication within the microbial community, leading to severe pathogenic outbreaks. <b>Methods & results:</b> Novel 1-(2-((5<i>H</i>-[1,2,4]-triazino[5,6-<i>b</i>]indol-3-yl)thio)acetyl)indoline-2,3-diones were synthesized. The title compounds exhibit outstanding anti-quorum-sensing efficacy, and compound <b>7g</b> demonstrated the maximum proficiency (IC<sub>50</sub> = 0.0504 μg/ml). The hybrids displayed potent antioxidant action, and compound <b>7c</b> showed the highest antioxidant ability (IC<sub>50</sub> = 40.71 μg/ml). Molecular docking of the isatin hybrids against DNA gyrase and quorum-sensing receptor CviR validated the observed <i>in vitro</i> findings. The befitting pharmacokinetic profile of the synthesized drug candidates was ascertained through absorption, distribution, metabolism, excretion and toxicity screening. <b>Conclusion:</b> The remarkable biocompetence of the synthesized triazinoindoles may help to combat drug-resistant infections.</p>\",\"PeriodicalId\":12475,\"journal\":{\"name\":\"Future medicinal chemistry\",\"volume\":\" \",\"pages\":\"399-416\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future medicinal chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4155/fmc-2023-0313\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/20 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4155/fmc-2023-0313","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Design, synthesis and exploration of novel triazinoindoles as potent quorum-sensing inhibitors and radical quenchers.
Background: Antimicrobial resistance has become a critical health concern, and quorum-sensing exacerbates the resistance by facilitating cell-to-cell communication within the microbial community, leading to severe pathogenic outbreaks. Methods & results: Novel 1-(2-((5H-[1,2,4]-triazino[5,6-b]indol-3-yl)thio)acetyl)indoline-2,3-diones were synthesized. The title compounds exhibit outstanding anti-quorum-sensing efficacy, and compound 7g demonstrated the maximum proficiency (IC50 = 0.0504 μg/ml). The hybrids displayed potent antioxidant action, and compound 7c showed the highest antioxidant ability (IC50 = 40.71 μg/ml). Molecular docking of the isatin hybrids against DNA gyrase and quorum-sensing receptor CviR validated the observed in vitro findings. The befitting pharmacokinetic profile of the synthesized drug candidates was ascertained through absorption, distribution, metabolism, excretion and toxicity screening. Conclusion: The remarkable biocompetence of the synthesized triazinoindoles may help to combat drug-resistant infections.
期刊介绍:
Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.